Real-time enrollment status for this merkel cell carcinoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 7:30 PM UTC
| NCT Number | NCT04975152 |
| Recruiting Status | Recruiting |
| Condition | Merkel Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of September 7, 2026: Clinical trial NCT04975152 is currently recruiting participants. This phase1 study for merkel cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04975152 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04975152 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.